DEA and HHS have delayed implementation of two rules for telehealth prescribing of buprenorphine until the end of the year to ...

The DEA and HHS have postponed the implementation of the final rule on telemedicine prescribing of buprenorphine to Dec. 31.

The Drug Enforcement Administration and Department of Health and Human Services yesterday announced that the effective date ...

In January, the U.S. Drug Enforcement Administration announced new rules to make permanent expanded telehealth access that ...

Patients who struggle with opioid addiction and who are treated by California emergency department physicians are remarkably successful at achieving long-term engagement in treatment and recovery, ...

This study builds on previous research exploring traditional daily treatments like methadone and buprenorphine for currently and recently incarcerated populations. While effective, these ...

The cause of death for a man who died at the Boone County jail in August was determined to be severe methamphetamine ...

Although nearly midnight, the team members, known as “Night Navigators,” connected him via telephone to the San Francisco Department of Public Health’s (SFDPH) telehealth buprenorphine ...

Increasing prevalence of cancer Drives Buprenorphine Market Growth from USD 5.52 Bn in 2023 • In terms of Application, the Opioid segment is expected to exhibit the highest share during the forecast ...

Dyersburg man charged with firearm and drug offenses after a dog shooting incident led to a broader investigation.

We are excited to present four posters with important real-world data from our differentiated pain portfolio at PainConnect 2025 and are grateful to AAPM for selecting our poster at its meeting as a ...

Buprenorphine is a highly effective medication that treats opioid cravings, related depression, and withdrawal symptoms. Buprenorphine is an inexpensive and safe treatment for OUD and that has ...